Article

Volta Labs announced major product launches and partnerships at AGBT 2026, including the integration of Roche's AXELIOS 1 into its Callisto platform and a new PCR-free WGS Complete Kit with Watchmaker Genomics. These developments aim to enhance automated genomic sequencing capabilities and streamline workflows for next-generation sequencers. The partnerships emphasize Callisto's role as a universal automation platform for diverse genomic applications.